Client Management | Digital KYC | Transactions | Investor App | AUM & Brokerage Reports | Lead Management | Automated Follow-Ups | MF Research | Multi-Asset Tracking
Login
Get Started
Home Mf Research Hdfc Pharma And Healthcare Fund Regular Plan Growth
HDFC Mutual Fund

Mutual Fund Research

HDFC Pharma And Healthcare Fund - Regular Plan - Growth

HDFC Mutual Fund Equity Equity Sectoral Thematic

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-28 ₹1,000.00 ₹1,035.19 +3.52%
Two Week 2026-10-21 ₹1,000.00 ₹1,079.52 +7.95%
One Month 2026-10-05 ₹1,000.00 ₹1,031.55 +3.15%
Three Months 2026-08-06 ₹3,000.00 ₹3,045.16 +1.51%
Six Months 2026-05-08 ₹6,000.00 ₹6,345.90 +5.76%
One Year 2025-11-04 ₹12,000.00 ₹13,982.97 +16.52%
Three Year 2023-11-06 ₹36,000.00 ₹50,532.19 +40.37%
Since Inception 2023-10-04 ₹38,000.00 ₹53,902.03 +41.85%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 71.27%
Healthcare Services 22.13%
Other 3.23%
Healthcare Equipment & Supplies 2.36%
Retailing 1.01%

Top Holdings

Company-wise portfolio exposure

Divis Laboratories Ltd. 9.39%
Sun Pharmaceutical Industries Ltd. 8.28%
Alkem Laboratories Ltd. 4.64%
Cipla Ltd. 4.15%
Apollo Hospitals Enterprise Ltd. 3.69%
Torrent Pharmaceuticals Ltd. 3.65%
Max Healthcare Institute Limited 3.61%
Aster DM Quality Care Limited 3.56%
Lupin Ltd. 3.55%
Neuland Laboratories Limited 3.24%
Shilpa Medicare Ltd 3.23%
Dr Reddys Laboratories Ltd. 3.19%
Acutaas Chemicals Limited 3.18%
Anthem Biosciences Limited 3.17%
Ipca Laboratories Ltd. 2.98%
Global Health Limited 2.72%
Rubicon Research Limited 2.52%
Krishna Institute Of Medical Sciences Limited 2.10%
Glenmark Pharmaceuticals Ltd. 2.09%
Molbio Diagnostics Limited 2.01%
Vijaya Diagnostic Centre Limited 2.00%
Zydus Lifesciences Limited 1.82%
Gland Pharma Ltd. 1.78%
Wockhardt Ltd. 1.71%
Jupiter Life Line Hospitals Limited 1.68%
Metropolis Healthcare Ltd. 1.67%
Sai Life Sciences Limited 1.58%
Biocon Ltd. 1.47%
SYMBIOTEC PHARMALAB LIMITED 1.36%
Thyrocare Technologies Ltd. 1.10%
CORONA REMEDIES LIMITED 1.04%
Entero Healthcare Solutions Limited 1.01%
Jubilant Pharmova Limited 0.93%
Eris Lifesciences Ltd 0.92%
Novartis India Ltd. 0.55%
BAJAJ HEALTHCARE LIMITED 0.53%
Laxmi Dental Limited 0.35%
Cohance Lifesciences Limited 0.32%
TREPS - Tri-party Repo 4.67%
Net Current Assets -1.44%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
16.29%
Return volatility
β
Beta
0.944
Benchmark sensitivity
S
Sharpe Ratio
1.383
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Peer Comparison

Compare similar mutual funds by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Nippon India Taiwan Equity Fund - Regular Plan - Growth 59.11% 48.18% 22.89%
Kotak Healthcare Fund - Regular Plan - Growth 21.83% 0.00% 19.25%
ICICI Prudential US Bluechip Equity Fund - Regular Plan - Growth 20.30% 18.34% 15.87%
Nippon India - Japan Equity Fund - Regular Plan - Growth 20.05% 20.38% 8.48%
SBI Automotive Opportunities Fund - Regular Plan - Growth 18.72% 0.00% 10.86%
Mirae Asset Healthcare Fund - Regular Plan - Growth 17.38% 22.11% 20.05%
Whiteoak Capital - Pharma And Healthcare Fund - Regular Plan - Growth 17.07% 0.00% 20.11%
Bajaj Finserv Healthcare Fund - Regular Plan - Growth 16.66% 0.00% 8.50%
SBI Healthcare Opportunities Fund - Regular Plan - Growth 16.50% 23.22% 15.44%
PGIM India Healthcare Fund - Regular Plan - Growth 16.27% 0.00% 9.01%

Returns are historical and do not guarantee future performance.

View All Equity Sectoral Thematic Funds

Fund Family

Compare schemes from HDFC Mutual Fund by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
HDFC Developed World Overseas Equity Passive FOF - Regular Plan 24.97% 24.62% 16.63%
HDFC Pharma And Healthcare Fund - Regular Plan - Growth 22.21% 29.08% 28.07%
HDFC Silver ETF Fund Of Fund - Regular Plan - Growth 15.79% 32.68% 29.61%
HDFC Defence Fund - Regular Plan - Growth 14.40% 33.71% 35.91%
HDFC Gold ETF Bse Scrip Code: 533230 Nse Symbol: Hdfcgold - Regular Plan 13.18% 29.73% 19.99%
HDFC Gold ETF Fund Of Fund - Regular Plan - Growth 12.27% 29.14% 9.70%
HDFC Innovation Fund - Regular Plan - Growth 10.11% 0.00% 11.72%
HDFC Crisil-IBX Fin Services 3-6 Months Debt Index Fund - Regular Plan - Growth 6.73% 0.00% 6.77%
HDFC Liquid Fund - Regular Plan - Growth 6.36% 6.78% 6.14%
HDFC Arbitrage Fund - Regular Plan - Growth 6.24% 6.73% 6.49%

Returns are historical and do not guarantee future performance.

View All HDFC Mutual Fund Funds

Scheme Objective

The investment mandate and purpose of this scheme

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.11%
Expense Ratio (Direct)
1.03%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare Index (TRI)

Exit Load

Charges that may apply when you redeem units

An Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.
Top AMC/Fund Houses
360 ONE Mutual Fund AMC logo
360 ONE Mutual Fund
AUM
₹13,053 Cr
Age
15+ Years
Aditya Birla Sun Life Mutual Fund AMC logo
Aditya Birla Sun Life Mutual Fund
AUM
₹4.36 Lakh Cr
Age
31+ Years
Helios Mutual Fund AMC logo
Helios Mutual Fund
AUM
₹9,401 Cr
Age
1–2 Years
Bandhan Mutual Fund AMC logo
Bandhan Mutual Fund
AUM
₹1.78+ Lakh Cr
Age
4 Years
view all

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?